Incyte Corp
NASDAQ:INCY

Watchlist Manager

Incyte Corp

NASDAQ:INCY

Watchlist

Earnings Calls

Price: 62.11 USD -0.93% Market Closed

Updated: Jun 15, 2024

Have any thoughts about
Incyte Corp?

Write Note

Write Note Ask AI

Add Note Why Create Notes?

Capture your thoughts

Note Buy Sell Hold Pass

US	Johnson & Johnson NYSE:JNJ	Pharmaceuticals
US	Berkshire Hathaway Inc NYSE:BRK.A	Financial Services
US	Bank of America Corp NYSE:BAC	Banking
US	Mastercard Inc NYSE:MA	Technology
US	Abbvie Inc NYSE:ABBV	Biotechnology
US	Pfizer Inc NYSE:PFE	Pharmaceuticals
US	Palantir Technologies Inc NYSE:PLTR	Technology
US	Nike Inc NYSE:NKE	Textiles, Apparel & Luxury Goods
US	Visa Inc NYSE:V	Technology
CN	Alibaba Group Holding Ltd NYSE:BABA	Retail
US	3M Co NYSE:MMM	Industrial Conglomerates
US	JPMorgan Chase & Co NYSE:JPM	Banking
US	Coca-Cola Co NYSE:KO	Beverages
US	Realty Income Corp NYSE:O	Real Estate
US	Verizon Communications Inc NYSE:VZ	Telecommunication
US	Walt Disney Co NYSE:DIS	Media

If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.

Peter Lynch

Track and Analyze Performance

Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.

Continuous Learning and Adaptation

Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.

Boost Decision Confidence

With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.

Why create notes?

Back

Delete Note

This note will be permanently deleted.

Delete

Cancel

Ask me anything about

Incyte Corp

What unique competitive advantages
does Incyte Corp hold over its rivals?

What risks and challenges
does Incyte Corp face in the near future?

Is it considered overvalued or undervalued
based on the latest financial data?

Provide an overview of the primary business activities
of Incyte Corp.

What unique competitive advantages
does Incyte Corp hold over its rivals?

What risks and challenges
does Incyte Corp face in the near future?

Has there been any significant insider trading activity
in Incyte Corp recently?

Summarize the latest earnings call
of Incyte Corp.

Is it considered overvalued or undervalued
based on the latest financial data?

Show all valuation multiples
for Incyte Corp.

Provide P/S
for Incyte Corp.

Provide P/E
for Incyte Corp.

Provide P/OCF
for Incyte Corp.

Provide P/FCFE
for Incyte Corp.

Provide P/B
for Incyte Corp.

Provide EV/S
for Incyte Corp.

Provide EV/GP
for Incyte Corp.

Provide EV/EBITDA
for Incyte Corp.

Provide EV/EBIT
for Incyte Corp.

Provide EV/OCF
for Incyte Corp.

Provide EV/FCFF
for Incyte Corp.

Provide EV/IC
for Incyte Corp.

Show me price targets
for Incyte Corp made by professional analysts.

What are the Revenue projections
for Incyte Corp?

How accurate were the past Revenue estimates
for Incyte Corp?

What are the Net Income projections
for Incyte Corp?

How accurate were the past Net Income estimates
for Incyte Corp?

What are the EPS projections
for Incyte Corp?

How accurate were the past EPS estimates
for Incyte Corp?

What are the EBIT projections
for Incyte Corp?

How accurate were the past EBIT estimates
for Incyte Corp?

Compare the revenue forecasts
for Incyte Corp with those of its competitors based on recent analyst estimates.

Compare the intrinsic valuations
of Incyte Corp and its key competitors using the latest financial data.

Compare historical revenue growth rates
of Incyte Corp against its competitors.

Analyze the profit margins
(gross, operating, and net) of Incyte Corp compared to its peers.

Compare the P/E ratios
of Incyte Corp against its peers.

Discuss the investment returns and shareholder value creation
comparing Incyte Corp with its peers.

Analyze the financial leverage
of Incyte Corp compared to its main competitors.

Show all profitability ratios
for Incyte Corp.

Provide ROE
for Incyte Corp.

Provide ROA
for Incyte Corp.

Provide ROIC
for Incyte Corp.

Provide ROCE
for Incyte Corp.

Provide Gross Margin
for Incyte Corp.

Provide Operating Margin
for Incyte Corp.

Provide Net Margin
for Incyte Corp.

Provide FCF Margin
for Incyte Corp.

Show all solvency ratios
for Incyte Corp.

Provide D/E Ratio
for Incyte Corp.

Provide D/A Ratio
for Incyte Corp.

Provide Interest Coverage Ratio
for Incyte Corp.

Provide Altman Z-Score Ratio
for Incyte Corp.

Provide Quick Ratio
for Incyte Corp.

Provide Current Ratio
for Incyte Corp.

Provide Cash Ratio
for Incyte Corp.

What is the historical Revenue growth
over the last 5 years for Incyte Corp?

What is the historical Net Income growth
over the last 5 years for Incyte Corp?

What is the current Free Cash Flow
of Incyte Corp?

Discuss the annual earnings per share (EPS)
trend over the past five years for Incyte Corp.

INCY

Balance Sheet

Accumulated Depreciation

Incyte Corp
Accumulated Depreciation

Last Value

3-Years 3-Y CAGR

5-Years 5-Y CAGR

10-Years 10-Y CAGR

Quarterly

Annual

Adjust for Inflation

Incyte Corp
Accumulated Depreciation Peer Comparison

Comparables:

ABBV

GILD

AMGN

VRTX

REGN

Competitive Accumulated Depreciation Analysis
Latest Figures & CAGR of Competitors

	Accumulated Depreciation	CAGR 3Y	CAGR 5Y	CAGR 10Y
Incyte Corp NASDAQ:INCY	Accumulated Depreciation -$282.9m	CAGR 3-Years -23%	CAGR 5-Years -20%	CAGR 10-Years -24%
Abbvie Inc NYSE:ABBV	Accumulated Depreciation -$6.7B	CAGR 3-Years -6%	CAGR 5-Years -4%	CAGR 10-Years -4%
Gilead Sciences Inc NASDAQ:GILD	Accumulated Depreciation N/A	CAGR 3-Years N/A	CAGR 5-Years N/A	CAGR 10-Years N/A
Amgen Inc NASDAQ:AMGN	Accumulated Depreciation N/A	CAGR 3-Years N/A	CAGR 5-Years N/A	CAGR 10-Years N/A
Vertex Pharmaceuticals Inc NASDAQ:VRTX	Accumulated Depreciation N/A	CAGR 3-Years N/A	CAGR 5-Years N/A	CAGR 10-Years N/A
Regeneron Pharmaceuticals Inc NASDAQ:REGN	Accumulated Depreciation N/A	CAGR 3-Years N/A	CAGR 5-Years N/A	CAGR 10-Years N/A

What is Incyte Corp's Accumulated Depreciation?

Accumulated Depreciation
-282.9m USD

Based on the financial report for Mar 31, 2024, Incyte Corp's Accumulated Depreciation amounts to -282.9m USD.

What is Incyte Corp's Accumulated Depreciation growth rate?

Accumulated Depreciation CAGR 10Y
-24%

Over the last year, the Accumulated Depreciation growth was -25%. The average annual Accumulated Depreciation growth rates for Incyte Corp have been -23% over the past three years , -20% over the past five years , and -24% over the past ten years .

Incyte Corp
NASDAQ:INCY

Incyte Corp
Accumulated Depreciation

Incyte Corp
Accumulated Depreciation Peer Comparison

Competitive Accumulated Depreciation Analysis
Latest Figures & CAGR of Competitors

See Also

What is Incyte Corp's Accumulated Depreciation?

Accumulated Depreciation
-282.9m USD

What is Incyte Corp's Accumulated Depreciation growth rate?

Accumulated Depreciation CAGR 10Y
-24%

Company

Help

Tools

Stocks

Incyte Corp NASDAQ:INCY

Incyte Corp Accumulated Depreciation

Incyte Corp Accumulated Depreciation Peer Comparison

Competitive Accumulated Depreciation Analysis Latest Figures & CAGR of Competitors

See Also

What is Incyte Corp's Accumulated Depreciation? Accumulated Depreciation -282.9m USD

What is Incyte Corp's Accumulated Depreciation growth rate? Accumulated Depreciation CAGR 10Y -24%

Company

Help

Tools

Stocks

Incyte Corp
NASDAQ:INCY

Incyte Corp
Accumulated Depreciation

Incyte Corp
Accumulated Depreciation Peer Comparison

Competitive Accumulated Depreciation Analysis
Latest Figures & CAGR of Competitors

What is Incyte Corp's Accumulated Depreciation?

Accumulated Depreciation
-282.9m USD

What is Incyte Corp's Accumulated Depreciation growth rate?

Accumulated Depreciation CAGR 10Y
-24%